Matías Muñoz-Uribe

Mr. Matías Muñoz-Uribe

Physiology, Pontificia Universidad Católica de Chile, Santiago, Región Metropolitana, Chile
+1
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2020 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
FLFreddy López-Contreras
Freddy López-Contreras
MMMatías Muñoz-Uribe
Matías Muñoz-Uribe
JPJorge Pérez-Laines
Jorge Pérez-Laines
LALaura Ascencio-Leal
Laura Ascencio-Leal
ARAndrés Rivera-Dictter
Andrés Rivera-Dictter
RLRodrigo López-Muñoz
Rodrigo López-Muñoz
Non-small cell lung cancer (NSCLC) is the most lethal and prevalent type of lung cancer. In almost all types of cancer, the levels of polyamines (putrescine, spermidine, and spermine) are increased, playing a pivotal role in tumor proliferation. Indomethacin, a non-steroidal anti-inflammatory drug, increases the abundance of an enzyme termed spermidine/spermine-N1-acetyltransferase (SSAT) encoded by the SAT1 gene. This enzyme is a key player in the export of polyamines from the cell. The aim of this study was to compare the effect of indomethacin on two NSCLC cell lines, and their combinatory potential with polyamine-inhibitor drugs in NSCLC cell lines. A549 and H1299 NSCLC cells were exposed to indomethacin and evaluations included SAT1 expression, SSAT levels, and the metabolic status of cells. Moreover, the difference in polyamine synthesis enzymes among these cell lines as well as the synergistic effect of indomethacin and chemical inhibitors of the polyamine pathway enzymes on cell viability were investigated. Indomethacin increased the expression of SAT1 and levels of SSAT in both cell lines. In A549 cells, it significantly reduced the levels of putrescine and spermidine. However, in H1299 cells, the impact of treatment on the polyamine pathway was insignificant. Also, the metabolic features upstream of the polyamine pathway (i.e., ornithine and methionine) were increased. In A549 cells, the increase of ornithine correlated with the increase of several metabolites involved in the urea cycle. Evaluation of the levels of the polyamine synthesis enzymes showed that ornithine decarboxylase is increased in A549 cells, whereas S-adenosylmethionine-decarboxylase and polyamine oxidase are increased in H1299 cells. This observation correlated with relative resistance to polyamine synthesis inhibitors eflornithine and SAM486 (inhibitors of ornithine decarboxylase and S-adenosyl-L-methionine decarboxylase, respectively), and MDL72527 (inhibitor of polyamine oxidase and spermine oxidase). Finally, indomethacin demonstrated a synergistic effect with MDL72527 in A549 cells and SAM486 in H1299 cells. Collectively, these results indicate that indomethacin alters polyamine metabolism in NSCLC cells and enhances the effect of polyamine synthesis inhibitors, such as MDL72527 or SAM486. However, this effect varies depending on the basal metabolic fingerprint of each type of cancer cell.

16 December 2016 in Journal of Fish Diseases
Verified
Journal Article
Closed access
PDF file
CCC Cartes
C Cartes
AIA Isla
A Isla
FLF Lagos
F Lagos
DCD Castro
D Castro
MMMatías Muñoz-Uribe
Matías Muñoz-Uribe
Jaime Figueroa V.Jaime Figueroa V.
Jaime Figueroa V.

16 June 2023 in Journal of Vascular Research
Verified
Journal Article
Closed access
MMMónica Márquez
Mónica Márquez
MMMatías Muñoz-Uribe
Matías Muñoz-Uribe
ACAlexandra Córdova
Alexandra Córdova
MPMariela Puebla
Mariela Puebla
XFXavier Figueroa
Xavier Figueroa
Vascular system is a complex network in which different cell types and vascular segments must work in concert to regulate blood flow distribution and arterial blood pressure. Although paracrine/autocrine signaling is involved in the regulation of vasomotor tone, direct intercellular communication via gap junctions plays a central role in the control and coordination of vascular function in the microvascular network. Gap junctions are made up by connexin (Cx) proteins, and among the four Cxs expressed in the cardiovascular system (Cx37, Cx40, Cx43, and Cx45), Cx40 has emerged as a critical signaling pathway in the vessel wall. This Cx is predominantly found in the endothelium, but it is involved in the development of the cardiovascular system and in the coordination of endothelial and smooth muscle cell function along the length of the vessels. In addition, Cx40 participates in the control of vasomotor tone through the transmission of electrical signals from the endothelium to the underlying smooth muscle and in the regulation of arterial blood pressure by renin-angiotensin system in afferent arterioles. In this review, we discuss the participation of Cx40-formed channels in the development of cardiovascular system, control and coordination of vascular function, and regulation of arterial blood pressure.

12 September 2023 in Biomolecules
Verified
Journal Article
Open access
PDF file
NBNeudo Buelvas
Neudo Buelvas
IUIsidora Ugarte-Vio
Isidora Ugarte-Vio
LALaura Asencio-Leal
Laura Asencio-Leal
MMMatías Muñoz-Uribe
Matías Muñoz-Uribe
AMAntonia Martin-Martin
Antonia Martin-Martin
RLRodrigo López-Muñoz
Rodrigo López-Muñoz
Indomethacin is a non-selective NSAID used against pain and inflammation. Although cyclooxygenase (COX) inhibition is considered indomethacin’s primary action mechanism, COX-independent ways are associated with beneficial effects in cancer. In colon cancer cells, the activation of the peroxisome proliferator-activated receptor-γ (PPAR-γ) is related to the increase in spermidine/spermine-N1-acetyltransferase-1 (SSAT-1), a key enzyme for polyamine degradation, and related to cell cycle arrest. Indomethacin increases the SSAT-1 levels in lung cancer cells; however, the mechanism relying on the SSAT-1 increase is unclear. Thus, we asked for the influence of the PPAR-γ on the SSAT-1 expression in two lung cancer cell lines: H1299 and A549. We found that the inhibition of PPAR-γ with GW9662 did not revert the increase in SSAT-1 induced by indomethacin. Because the mRNA of SSAT-1 suffers a pre-translation retention step by nucleolin, a nucleolar protein, we explored the relationship between indomethacin and the upstream translation regulators of SSAT-1. We found that indomethacin decreases the nucleolin levels and the cyclin-dependent kinase 1 (CDK1) levels, which phosphorylates nucleolin in mitosis. Overexpression of nucleolin partially reverts the effect of indomethacin over cell viability and SSAT-1 levels. On the other hand, Casein Kinase, known for phosphorylating nucleolin during interphase, is not modified by indomethacin. SSAT-1 exerts its antiproliferative effect by acetylating polyamines, a process reverted by the polyamine oxidase (PAOX). Recently, methoctramine was described as the most specific inhibitor of PAOX. Thus, we asked if methoctramine could increase the effect of indomethacin. We found that, when combined, indomethacin and methoctramine have a synergistic effect against NSCLC cells in vitro. These results suggest that indomethacin increases the SSAT-1 levels by reducing the CDK1-nucleolin regulatory axis, and the PAOX inhibition with methoctramine could improve the antiproliferative effect of indomethacin.

18 May 2019 in Molecules
Verified
Journal Article
Open access
PDF file
AMAntonia Martin-Martin
Antonia Martin-Martin
ARAndrés Rivera-Dictter
Andrés Rivera-Dictter
MMMatías Muñoz-Uribe
Matías Muñoz-Uribe
FLFreddy López-Contreras
Freddy López-Contreras
JPJorge Pérez-Laines
Jorge Pérez-Laines
RLRodrigo López-Muñoz
Rodrigo López-Muñoz
Nitric oxide-releasing aspirins (NO-aspirins) are aspirin derivatives that are safer than the parent drug in the gastrointestinal context and have shown superior cytotoxic effects in several cancer models. Despite the rationale for their design, the influence of nitric oxide (NO•) on the effects of NO-aspirins has been queried. Moreover, different isomers exhibit varying antitumor activity, apparently related to their ability to release NO•. Here, we investigated the effects and mode of action of NO-aspirins in non-small-cell lung cancer (NSCLC) cells, comparing two isomers, NCX4016 and NCX4040 (-meta and -para isomers, respectively). NCX4040 was more potent in decreasing NSCLC cell viability and migration and exhibited significant synergistic effects in combination with erlotinib (an epidermal growth factor receptor inhibitor) in erlotinib-resistant cells. We also studied the relationship among the effects of NO-aspirins, NO• release, and PGE2 levels. NCX4040 released more NO• and significantly decreased PGE2 synthesis relative to NCX4016; however, NO• scavenger treatment reversed the antiproliferative effects of NCX4016, but not those of NCX4040. By contrast, misoprostol (a PGE2 receptor agonist) significantly reversed the antiproliferative effect of NCX4040, but not those of NCX4016. Furthermore, misoprostol reversed the antimigratory effects of NCX4040. Overall, these results indicate that PGE2 inhibition is important in the mode of action of NO-aspirins.

3 September 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
NBNelson P Barrera
Nelson P Barrera
MMMonica Marquez
Monica Marquez
MMMatías Muñoz-Uribe
Matías Muñoz-Uribe
XFXavier Figueroa
Xavier Figueroa
Conduction of vasodilator signals plays an important role in the coordination of blood flow distribution. It is thought that endothelium-dependent vasodilation’s are conducted by electrotonic spread through gap junctions of the endothelial cell hyperpolarization generated at the stimulation site. However, nitric oxide (NO) was found to reduce the propagation of vasodilator responses, suggesting the participation of this signaling molecule in the mechanism of conduction. Mouse cremasteric arterioles were stimulated through micro-application of ACh or the NO donor, S-nitroso-N-acetylpenicillamine (SNAP) and the responses were evaluated at the stimulation site (local) and at sites located 500, 1000 and 2000 µm upstream from the vessel segment stimulated with ACh. The response to ACh spread along the entire vessel showing a slight decay and, in contrast, the dilation evoked by SNAP was restricted to the stimulation site, independently of the magnitude of the response. Blockade of NO production with 100 µM NG-nitro-L-arginine methyl ester (L-NAME) or 100 µM NG-nitro-L-arginine (L-NA) reduced the resting diameter by 10-12% (n=4), but the combination of two NO blockers enhanced the basal vasoconstrictor tone by ~38% (n=5) and inhibited the local (~45%) and conducted (~20-35%) responses to ACh. Interestingly, the conduction of ACh-induced vasodilation increased along the vessel length in the presence of L-NAME and L-NA. In addition, endothelial cell hyperpolarization blockade exclusively at the stimulation site through microsuperfusion of tetraethylammonium inhibited the local vasodilation, but not the conduction of the response. These results indicate that ACh activates a NO-sensitive regenerative vasodilator mechanism that is coupled to the activation of NO production and endothelium-dependent hyperpolarization along the vessel length.